Sebastian Wahl and Carl-Philipp von Polheim are the founders of mybacs. Mybacs is a direct-to-consumer (D2C), research driven, biotechnology company for gut-health products based in Zug (Switzerland) and Munich (Germany). Their goal is to revolutionize the healthcare market around the human microbiome and thus make a decisive contribution to the health and daily well-being of everyday customers. Mybacs is specialized on the development of innovative and high-dose synbiotic dietary supplements They have two types of products - a Travel and Daily well-being probiotic product.

Sebastian holds a Master's degree with distinction in Pharmacy from